Praveen Tumula, M.D., FACP
Medical Oncology, Genetic Evaluation, Hematology


About
Praveen Tumula, M.D., FACP, is board certified in hematology, internal medicine, and medical oncology. Dr. Tumula is Texas Oncology’s regional medical director for Abilene, Amarillo, Midland, Odessa, and Wichita Falls. His personal experience of knowing someone with cancer, and the accompanying feelings of helplessness, spurred his pursuit of oncology. His aspiration is to make a significant impact, be on forefront of the fight against cancer, and offer hope and support.
Dr. Tumula strives to build genuine relationships – connecting on a personal level, understanding your fears, hopes, and unique stories. He becomes more than just a physician; he becomes a trusted confidant and guide through the complexities of cancer care. It is about empowering you with knowledge and being a steady support throughout your journey. Being part of your story, witnessing your resilience and courage, and knowing he played a role in your fight against cancer is meaningful to him.
Spending quality time with family, cooking and traveling help him relax and unwind. Dr. Tumula encourages finding activities to relax your mind. Engaging in interests that bring joy and relaxation has a positive impact on overall well-being. A less stressful mind translates into a better immune system, which is essential to maintain health.
Experience
Education
Fellowship in Hematology and Oncology
Boston University Medical Center, Boston, MA
Residency in Internal Medicine
Hackensack University Medical Center Mountainside Hospital, Montclair, NJ
Internship in Internal Medicine
Hackensack University Medical Center Mountainside Hospital, Montclair, NJ
Medical Doctorate
N.T.R University of Health Sciences, A.P., India
Unable to load video. Please check the video ID and try again.
Condition
Acute Lymphocytic Leukemia
Condition
Adrenal Cancer
Condition
Adult Acute Lymphoblastic LeukemiaCondition
Anal Cancer
Condition
Anemia
Condition
Acute Myeloid LeukemiaCondition
Appendiceal Cancer
Condition
Bladder CancerCondition
Bone CancerCondition
Brain CancerCondition
Chest Wall TumorCondition
Chronic Lymphocytic LeukemiaCondition
Chronic Myeloid LeukemiaCondition
Colon CancerCondition
Colon & Rectal CancerCondition
Esophageal CancerCondition
Gastric CancerCondition
Hemophilia
Condition
Hodgkin LymphomaCondition
HypercalcemiaCondition
Kidney CancerCondition
Larynx CancerCondition
LeukemiaCondition
Liver CancerCondition
Lung CancerCondition
Lymphoma
Condition
MelanomaCondition
MesotheliomaCondition
Multiple MyelomaCondition
Myelodysplastic SyndromeCondition
Myeloproliferative Neoplasms (MPN)Condition
Pancreatic CancerCondition
Penile Cancer
Condition
Primary Peritoneal Mesotheliaoma
Condition
Prostate CancerCondition
Pseudomyxoma Peritonei
Condition
Rectal CancerCondition
Renal CancerCondition
SarcomaCondition
Skin CancerCondition
Stomach CancerCondition
Testicular CancerCondition
Thyroid CancerCondition
Urologic CancersCondition
Urothelial Cancer
Service
Precision MedicineService
High Risk Surveillance and Prevention
Treatment
ImmunotherapyTreatment
Second Opinion Consultation
Treatment
ChemotherapyLocations